Literature DB >> 25955390

Trends and regional variation in the incidence of head and neck cancers in England: 2002 to 2011.

Caroline E McCarthy1, John K Field2, Bijaya P Rajlawat1, Anne E Field1, Michael W Marcus2.   

Abstract

Recent studies show an increased incidence of head and neck cancers worldwide. The present study evaluated the trend in the incidence of head and neck cancers in England during 2002-2011. Data were extracted from the database of Office for National Statistics. The study population was categorised according to age, residential area, gender and cancer sub-types. Overall trend in incidence of head and neck cancer and some subtypes were examined using Poisson regression models. In total, 71,457 head and neck cancers were registered in England between 2002 and 2011 and 68% of patients were males. Statistically significant increases in incidence of 27.0 and 32.4% were documented in males and females, respectively (p<0.001) with the largest increase in the 60+ age category. Potentially HPV-associated cancers, oral cavity cancers and laryngeal cancers increased by 47.1, 24.1 and 1.7% in males and 37.5, 25.5 and 7.7% in females, respectively (p<0.001). Regional differences were also noted with the highest incidence (18.0 and 17.0 per 100,000, respectively) in the North East and North West of England. Our results for England showed an increase in the incidence of both oral cavity and oropharyngeal cancer in both genders, whilst laryngeal cancer incidence remained stable.

Entities:  

Mesh:

Year:  2015        PMID: 25955390     DOI: 10.3892/ijo.2015.2990

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study.

Authors:  Moustafa Mourad; Thomas Jetmore; Ameya A Jategaonkar; Sami Moubayed; Erin Moshier; Mark L Urken
Journal:  J Oral Maxillofac Surg       Date:  2017-05-22       Impact factor: 1.895

2.  Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan.

Authors:  Daisuke Kawakita; Isao Oze; Shinichi Iwasaki; Tomohiro Matsuda; Keitaro Matsuo; Hidemi Ito
Journal:  Cancer Med       Date:  2022-01-14       Impact factor: 4.452

3.  DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer.

Authors:  Imran Petkar; Keith Rooney; Justin W G Roe; Joanne M Patterson; David Bernstein; Justine M Tyler; Marie A Emson; James P Morden; Kathrin Mertens; Elizabeth Miles; Matthew Beasley; Tom Roques; Shreerang A Bhide; Kate L Newbold; Kevin J Harrington; Emma Hall; Christopher M Nutting
Journal:  BMC Cancer       Date:  2016-10-06       Impact factor: 4.430

4.  Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe.

Authors:  Susanne Hartwig; Jean Lacau St Guily; Géraldine Dominiak-Felden; Laia Alemany; Silvia de Sanjosé
Journal:  Infect Agent Cancer       Date:  2017-04-11       Impact factor: 2.965

5.  Oral cancer incidence in Shanghai ---- a temporal trend analysis from 2003 to 2012.

Authors:  Jin-Ye Fu; Chun-Xiao Wu; Chen-Ping Zhang; Jing Gao; Jian-Feng Luo; Shu-Kun Shen; Ying Zheng; Zhi-Yuan Zhang
Journal:  BMC Cancer       Date:  2018-06-25       Impact factor: 4.430

6.  Application of red light phototherapy in the treatment of radioactive dermatitis in patients with head and neck cancer.

Authors:  Xudong Zhang; Hongfei Li; Qian Li; Ying Li; Chao Li; Minmin Zhu; Bing Zhao; Guowen Li
Journal:  World J Surg Oncol       Date:  2018-11-12       Impact factor: 2.754

7.  Estimated projection of oral cavity and oropharyngeal cancer deaths in Spain to 2044.

Authors:  Pedro Infante-Cossio; Antonio-Jose Duran-Romero; Antonio Castaño-Seiquer; Rafael Martinez-De-Fuentes; Jose-Juan Pereyra-Rodriguez
Journal:  BMC Oral Health       Date:  2022-10-14       Impact factor: 3.747

8.  Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.

Authors:  Nicole Brenner; Alexander J Mentzer; Michael Hill; Rachael Almond; Naomi Allen; Michael Pawlita; Tim Waterboer
Journal:  EBioMedicine       Date:  2020-11-25       Impact factor: 8.143

9.  HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology.

Authors:  Andrew G Schache; Ned G Powell; Kate S Cuschieri; Max Robinson; Sam Leary; Hisham Mehanna; Davy Rapozo; Anna Long; Heather Cubie; Elizabeth Junor; Hannah Monaghan; Kevin J Harrington; Christopher M Nutting; Ulrike Schick; Andy S Lau; Navdeep Upile; Jon Sheard; Kath Brougham; Catharine M L West; Ken Oguejiofor; Steve Thomas; Andy R Ness; Miranda Pring; Gareth J Thomas; Emma V King; Dennis J McCance; Jacqueline A James; Michael Moran; Phil Sloan; Richard J Shaw; Mererid Evans; Terry M Jones
Journal:  Cancer Res       Date:  2016-08-28       Impact factor: 13.312

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.